Drug Profile
NT KC 005
Alternative Names: NTKC005Latest Information Update: 28 Feb 2018
Price :
$50
*
At a glance
- Originator Neurotec Pharma
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Stroke
Most Recent Events
- 28 Feb 2018 No recent reports of development identified for preclinical development in Stroke in Spain
- 22 Feb 2016 NT KC 005 is still in preclinical phase trials for Stroke in Spain (Neurotec Pharma pipeline, February 2016)